Resources - Posters

MSDHIV.COM - Integrase Inhibition Integrase

RESOURCES— Posters

HIV8

8th International Congress on Drug Therapy in HIV Infection:
Glasgow, UK, 12-16 November 2006

Lack of a Pharmacokinetic Interaction of MK-0518 on Midazolam (MDZ)
(file size: 246KB) or download zip file (file size: 174KB)

Rifampin (RIF) Modestly Reduces Plasma Levels of MK-0518
(file size: 239KB) or download zip file (file size: 179KB)

ICAAC

46th Interscience Conference on Antimicrobial Agents and Chemotherapy:
San Francisco, California, USA, 27-30 September 2006

Absorption, Metabolism and Excretion of MK-0518, a Potent HIV-1 Integrase Inhibitor, in Healthy Male Volunteers
(file size: 483KB) or download zip file (file size: 280KB)

Minimal Effect of Ritonavir (RTV) and Efavirenz (EFV) on the Pharmacokinetics (PK) of MK-0518
(file size: 347KB) or download zip file (file size: 207KB)

Safety, Tolerability, and Pharmacokinetics After Single and Multiple Doses of MK-0518 in Healthy Subjects
(file size: 355KB) or download zip file (file size: 270KB)

IAC

XVI International AIDS Conference:
Toronto, Canada, 13-18 August 2006

Discovery of MK-0518, a Novel, Potent, and Selective HIV IntegraseInhibitor in Phase III Clinical Trials
(file size: 781KB) or download zip file (file size: 299KB)

Due to individual countries' requirements, not all uses or indications discussed in this Web site may have received regulatory approval in your country. Before prescribing any of the products mentioned in this Web site, please consult the local prescribing information available from the manufacturer.

†Trademark of Merck & Co., Inc., Whitehouse Station, NJ, USA